Clinic
Planned Parenthood of the Columbia/Willamette, INC.
Planned Parenthood of the Columbia/Willamette, INC. was paid $20.33M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 31% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD OF THE COLUMBIA/WILLAMETTE, INC.
PORTLAND, OR 97212
PORTLAND, OR 97212
33aNPI1053311860assigned 07/22/2005
33bProvider typeAmbulatory Family Planning Facility
28Total paid$20.33M
24GClaims389,162
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,594 | $2.23M | |
| 2019 | 85,532 | $4.38M | |
| 2020 | 58,568 | $3.64M | |
| 2021 | 50,872 | $2.72M | |
| 2022 | 43,725 | $2.29M | |
| 2023 | 50,068 | $2.45M | |
| 2024incomplete | 41,803 | $2.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 31% | 41,322 | 39,835 | $6.27M |
| S4993 | Contraceptive pills for birth control | 30% | 57,662 | 51,352 | $6.08M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 39,726 | 37,881 | $2.47M |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 5.7% | 2,916 | 2,903 | $1.16M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.8% | 10,191 | 9,853 | $571K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 2.5% | 2,211 | 2,203 | $510K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 9,307 | 8,809 | $406K |
| 81025 | 1.9% | 54,433 | 51,462 | $377K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 4,160 | 4,032 | $362K |
| S9430 | Pharmacy compounding and dispensing services | 1.6% | 4,391 | 4,217 | $326K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 3,189 | 3,043 | $290K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.0% | 12,407 | 12,373 | $209K |
34 more codes
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 10,853 | $160K |
| S4930 | <1% | 16,270 | $160K | |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 597 | $147K |
| 87806 | <1% | 6,659 | $146K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 26,578 | $95K |
| 86703 | <1% | 10,509 | $94K | |
| 55250 | <1% | 125 | $88K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,565 | $61K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,830 | $43K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,203 | $39K |
| 36416 | <1% | 19,818 | $35K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 1,364 | $30K |
| 57454 | <1% | 228 | $29K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 461 | $27K |
| 58300 | <1% | 118 | $27K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 4,143 | $23K |
| 87210 | <1% | 5,015 | $20K | |
| 11981 | <1% | 62 | $12K | |
| S5000 | Prescription drug, generic | <1% | 2,667 | $12K |
| 82120 | <1% | 2,601 | $11K | |
| 99000 | <1% | 19,298 | $8K | |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 37 | $8K |
| 83986 | <1% | 2,556 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 53 | $7K |
| Q3014 | Telehealth originating site facility fee | <1% | 213 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 40 | $4K |
| 99201 | <1% | 123 | $4K | |
| 11982 | <1% | 24 | $2K | |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | <1% | 73 | $916.47 |
| 58301 | <1% | 14 | $660.96 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 29 | $304.50 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 13 | $262.50 |
| 81002 | <1% | 75 | $213.90 | |
| 85018 | <1% | 33 | $40.81 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCROSS, STACY (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood of the Columbia/Willamette, INC. | Portland, OR | $26K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.